Online Share/Stock Trading & Investment Broker in India | mastertrust

Glaxosmithkline Consumer Healthcare Ltd.

BSE : 100676 NSE : GSKCONS ISIN : INE264A01014 Industry : Consumer Food
10,732.60
Change: 496.30 (4.85 %)
As on 15-Apr-2020 03:59 PM
Prev.Close 10,236.30
Open 10,310.00
Day's High 10,850.00
Day's Low 10,310.00
Mkt.Cap ( Cr.) 45,137.02
Face Value 10
PE Ratio 39.13
PB Ratio 7.41

52 Week High Low

Low: 7,180.30
High: 11,296.30
LTP:10,732.60

Lifetime High Low

Low: 4,708.00
High: 11,296.30
LTP:10,732.60

Glaxosmithkline Consumer Healthcare Ltd.

BSE : 100676 NSE : GSKCONS ISIN : INE264A01014 Industry : Consumer Food
10,753.65
B S Sip
Change: 521.30 (5.09 %)
As on 15-Apr-2020 12:00 AM
Prev.Close 10,232.35
Open 10,500.00
Day High 10,845.75
Day Low 10,394.05
Mkt.Cap ( Cr. ) 45,225.55
Face Value 10
P/E Ratio 39.13
PB Ratio 7.41

52 Week High Low

Low:7,188.35
High:11,290.00
LTP:10,753.65

Lifetime High Low

Low:3,645.00
High:8,137.95
LTP:10,753.65

P/E Ratio

52 W L(14.96)
52 W H(40.26)

P/E Ratio

52 W L(14.96)
52 W H(40.26)
Had I Invested a sum of 1,00,000 on the same day 5 years ago,the money would have become 168036.89 ( a of 10.94 p.a.)

Key Levels

Support Level 1 7,857.20
Support Level 2 7,747.40
Resistance Level 1 8,037.40
Resistance Level 2 8,107.80

Moving Average

20 Days 9,369.55
50 Days 9,406.30
100 Days 9,025.87
200 Days 8,507.39
Agro Tech Foods Ltd. 506.50 Change: 40.60 (8.71%)
PE : 29.46
1Y Return: -5.72%

B S
Vadilal Industries Ltd. 543.50 Change: 25.85 (4.99%)
PE : 7.67
1Y Return: -5.94%

B S
Kohinoor Foods Ltd. 8.10 Change: 0.25 (3.18%)
PE : 0.00
1Y Return: -70.81%

B S
Tasty Bite Eatables Ltd. 10,024.75 Change: 196.75 (2.00%)
PE : 61.67
1Y Return: 25.20%

B S
FY 2019FY 2018FY 2017FY 2016FY 2015
EBDITA Margin (%)32.9126.0624.3424.4421.01
PBT Margin (%)31.6224.5522.8323.1319.62
PAT Margin (%)20.5515.9914.8415.0612.88
ROCE (%)39.9232.5434.1042.9845.33
ROE (%)25.9321.1922.1827.9929.73
FY 2019FY 2018FY 2017FY 2016FY 2015
Total Income ( Cr.)5,214.614,573.924,230.344,413.784,529.47
Gross Profit ( Cr.)1,572.801,138.731,074.591,113.39951.23
Profit Before Tax ( Cr.)1,512.291,074.361,010.421,055.95889.14
Tax ( Cr.)529.49374.26353.74368.67305.54
Profit After Tax ( Cr.)982.80700.10656.68687.28583.60
NAME DESIGNATION
P Dwarakanath Chairman
Navneet Saluja Managing Director
Kunal Kashyap Non Executive Independent Director
Naresh Dayal Non Executive Independent Director
Sangeeta Talwar Non Executive Independent Director
S Madhavan Non Executive Independent Director
Vivek Anand Whole Time Director
Anup Dhingra Whole Time Director
Shanu Saksena Company Secretary
PV Bhide Non Executive Independent Director
No Data Available
Glaxo.Cons. Health reports Profit after tax of Rs 3453.10 Mln, in the September 2019 quarter
Type: CORPORATE RESULT
Date: 07-Nov-2019 03:42 PM
--
Glaxosmithkline Consumer Healthcare soars on reporting 35% rise in Q4 net profit
Type: MOVERS TODAY
Date: 13-May-2019 12:47 PM
For the year ended March 31, 2019, the company has reported a rise of 40.38% in its net profit
Glaxo.Cons. Health reports Profit after tax of Rs 2858.10 Mln, in the March 2019 quarter
Type: CORPORATE RESULT
Date: 10-May-2019 04:09 PM
--
GlaxoSmithKline Consumer Healthcare reports 26% rise in Q3 net profit
Type: NEWS
Date: 04-Feb-2019 02:13 PM
Total income of the company increased by 17.58% at Rs 841.77 crore for Q3FY19
GlaxoSmithKline Consumer Healthcare gets CCI’s nod for merger deal with HUL
Type: NEWS
Date: 28-Jan-2019 11:54 AM
The scheme remains subject to the receipt of other necessary statutory and regulatory approvals under applicable laws
GlaxoSmithKline Consumer Healthcare informs about company updates
Type: CORPORATE NEWS
Date: 04-Dec-2018 12:00 AM
--
ALERTS
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s,
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s,
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s,